Left ventricular assist device implantation is a challenging procedure in the presence of a giant thrombosed aneurysm, and no standard surgical techniques are currently recommended in this setting. In this case, we report the successful implantation of a left ventricular assist device (HeartMate III) in a patient with a massive thrombosed apical aneurysm. The patient presented with extended antero-apical necrosis as a result of a delay in hospital admission for acute coronary syndrome due to the patient’s concerns about the COVID-19 pandemic outbreak
We describe a case of 39 years old male underwent continuous flow LVAD implantation (HeartWare) HVAD...
A heavily calcified ventricular apex represents a challenging, rare and unique situation in LVAD imp...
Amid the coronavirus disease 2019 (COVID-19) pandemic, there is an unprecedented increase in public ...
Left ventricular assist device (LVAD) implantation is an established treatment for patients with end...
The novel coronavirus disease 2019 (COVID-19) is an infectious disease with multi-organ involvement,...
AbstractHeart failure is one of the leading causes of mortality and morbidity in the world. Heart tr...
Despite advances in technology, ventricular assist devices still experience a number of complication...
Systemic right ventricular failure is a common finding in patients with transposition of the great a...
Copyright © 2012 Jens Garbade et al. This is an open access article distributed under the Creative C...
The authors present the case of a 34-year-old male patient seen in our department due to palpitation...
PubMed ID: 23622612Background: In this report, we share our experience with left ventricular assist ...
Abstract Ventricular assist devices (VADs) are an important technological development for patients w...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
A 45-year-old man underwent repair of a congenital bicuspid aortic valve and complex aor-tic-root an...
We describe a case of 39 years old male underwent continuous flow LVAD implantation (HeartWare) HVAD...
We describe a case of 39 years old male underwent continuous flow LVAD implantation (HeartWare) HVAD...
A heavily calcified ventricular apex represents a challenging, rare and unique situation in LVAD imp...
Amid the coronavirus disease 2019 (COVID-19) pandemic, there is an unprecedented increase in public ...
Left ventricular assist device (LVAD) implantation is an established treatment for patients with end...
The novel coronavirus disease 2019 (COVID-19) is an infectious disease with multi-organ involvement,...
AbstractHeart failure is one of the leading causes of mortality and morbidity in the world. Heart tr...
Despite advances in technology, ventricular assist devices still experience a number of complication...
Systemic right ventricular failure is a common finding in patients with transposition of the great a...
Copyright © 2012 Jens Garbade et al. This is an open access article distributed under the Creative C...
The authors present the case of a 34-year-old male patient seen in our department due to palpitation...
PubMed ID: 23622612Background: In this report, we share our experience with left ventricular assist ...
Abstract Ventricular assist devices (VADs) are an important technological development for patients w...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
A 45-year-old man underwent repair of a congenital bicuspid aortic valve and complex aor-tic-root an...
We describe a case of 39 years old male underwent continuous flow LVAD implantation (HeartWare) HVAD...
We describe a case of 39 years old male underwent continuous flow LVAD implantation (HeartWare) HVAD...
A heavily calcified ventricular apex represents a challenging, rare and unique situation in LVAD imp...
Amid the coronavirus disease 2019 (COVID-19) pandemic, there is an unprecedented increase in public ...